The glycans deficiencies of macromolecular IgA1 is a contributory factor of variable pathological phenotypes of IgA nephropathy

Clinical and Experimental Immunology

Volumn 142, Issue 3, 2005, Pages 569-575

  Xu, L X ^a   Yan, Y ^a   Zhang, J J ^a   Zhang, Y ^a   Zhao, Ming Hui ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

Glycosylation; IgA nephropathy; IgA1 containing macromolecules; Pathology; Polyethylene glycol

Indexed keywords

GALACTOSE; IMMUNOGLOBULIN A; LECTIN; MACROGOL 6000; N ACETYLGALACTOSAMINE; SIALIC ACID;

ADULT; ARTICLE; BIOTINYLATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOGLOBULIN PRODUCING CELL; MACROMOLECULE; MALE; MESANGIUM CELL; PATHOGENESIS; PEANUT; PHENOTYPE; PRECIPITATION; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN GLYCOSYLATION; STATISTICAL SIGNIFICANCE;

ACETYLGALACTOSAMINE; ADULT; FEMALE; GALACTOSE; GLOMERULONEPHRITIS, IGA; GLYCOSYLATION; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; KIDNEY GLOMERULUS; LECTINS; MACROMOLECULAR SUBSTANCES; MALE; N-ACETYLNEURAMINIC ACID; PHENOTYPE; POLYSACCHARIDES; PRECIPITATION; SCLEROSIS; SEVERITY OF ILLNESS INDEX;

EID: 28344453175     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2005.02949.x     Document Type: Article

References (41)

1. D'Amico G. The commonest glomerulonephritis in the world: IgA nephropathy. Q J Med 1987; 64:709-27.
2. Donadio JV, Grande JP. Immunoglobulin A nephropathy: a clinical perspective. J Am Soc Nephrol 1997; 8:1324-31.
3. Donadio JV, Grande JP. Immunoglobulin A nephropathy. N Engl J Med 2002; 347:738-48.
4. Valentijn RM, Radl J, Haaijman JJ et al. Circulating and mesangial secretory component-binding IgA1 in primary IgA nephropathy. Kidney Int 1984; 26:760-6.
5. Trascasa ML, Egido J, Sancho J, Hernando L. IgA glomerulonephritis (Berger's disease): evidence of high serum levels of polymeric IgA. Clin Exp Immunol 1980; 42:247-54.
6. Leung JC, Tsang AW, Chan LY, Tang SC, Lam MF, Lai KN. Size-dependent binding of IgA to HepG2, U937, and human mesangial cells. J Lab Clin Med 2002; 140:398-406.
7. Novak J, Vu HL, Novak L, Julian BA, Mestecky J, Tomana M. Interactions of human mesangial cells with IgA and IgA-containing immune complexes. Kidney Int 2002; 62:465-75.
8. Wang Y, Zhao MH, Li XM, Zhang YK, Wang HY. Serum IgA1 from patients with IgA nephropathy induces phosphorylation of extracellular signal-regulated kinase and proliferation of human mesangial cells. Zhonghua Yi Xue Za Zhi 2002; 82:1406-9.
9. Wang Y, Zhao MH, Li XM, Zhang YK, Wang HY. Binding capacity and pathophysiological effects of IgA1 from patients with IgA nephropathy on human glomerular mesangial cells. Clin Exp Immunol 2004; 136:168-75.
10. Gomez-Guerrero C, Lopez-Armada MJ, Gonzalez E, Egido J. Soluble IgA and IgG aggregates are catabolized by cultured rat mesangial cells and induce production of TNF-alpha and IL-6, and proliferation. J Immunol 1994; 153:5247-55.
11. Lopez-Armada MJ, Gomez-Guerrero C, Egido J. Receptors for immne complexes activate gene expression and synthesis of matrix proteins in cultured rat and human mesangial cells: role of TGF-beta. Clin Exp Immunol 1997; 110:226-32.
12. van der Boog PJ, van Kooten C, van Seggelen A et al. An increased polymeric IgA level is not a prognostic marker for progressive IgA nephropathy. Nephrol Dial Transplant 2004; 19:2487-93.
13. Hiki Y, Tanaka A, Kokubo T et al. Analyses of IgA1 hinge glycopeptides in IgA nephropathy by matrix-assisted laser desorption/ ionization time-of-flight mass spectrometry. J Am Soc Nephrol 1998; 9:577-82.
14. Allen AC, Bailey EM, Barratt J, Buck KS, Feehally J. Analysis of IgA1 O-glycans in IgA nephropathy by fluorophore-assisted carbohydrate electrophoresis. J Am Soc Nephrol 1999; 10:1763-71.
15. Hashim OH, Shuib AS, Chua CT. Neuraminidase treatment abrogates the binding abnormality of IgA1 from IgA nephropathy patients and the differential charge distribution of its α-heavy chains. Nephron 2001; 89:422-5.
16. Leung JC, Tang SC, Lam MF, Chan TM, Lai KN. Charge-dependent binding of polymeric IgA1 to human mesangial cells in IgA nephropathy. Kidney Int 2001; 59:277-85.
17. Iwase H, Katsumata T, Itoh A et al. Detection of enriched Thomsen-Friedenrich antigen on IgA1 from IgA nephropathy patients. J Nephrol 2002; 15:703-8.
18. Sano T, Hiki Y, Kokubo T, Iwase H, Shigematsu H, Kobayashi Y. Enzymatically deglycosylated human IgA1 molecules accumulate and induce inflammatory cell reaction in rat glomeruli. Nephrol Dial Transplant 2002; 17:50-6.
19. Hiki Y, Odani H, Takahashi M et al. Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy. Kidney Int 2001; 59:1077-85.
20. Allen AC, Bailey EM, Brenchley PE, Buck KS, Barratt J, Feehally J. Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glycosylation: observations in three patients. Kidney Int 2001; 60:969-73.
21. Xu LX, Zhao MH. Aberrantly glycosylated serum IgA1 are closely associated with pathological phenotypes of IgA nephropathy. Kidnet Int 2005; 68:167-72.
22. Mark Haas. Histologic subclassification of IgA nephropathy: a clinicopathologic study of 244 cases. Am J Kidney Dis 1997; 29:829-42.
23. Pontes-de C, Lannes VJ, Giovanni SS, Galvao-Castro B. A protein A-binding, polyethylene glycol precipitation-based immunoradiometric assay. Application to the detection of immune complexes and C3 in human sera and of private antigens in cross-reacting parasite extracts. J Immunol Methods 1986; 89:27-35.
24. Kerr MA. The structure and function of IgA. Biochem J 1990; 271:285-96.
25. van den Wall Bake AW, Daha MR, Haaijman JJ, Radl J, van der Ark A, van Es LA. Elevated production of polymeric and monomeric IgA1 by the bone marrow in IgA nephropathy. Kidney Int 1989; 35:1400-4.
26. van den Wall Bake AW, Kirk KA, Gay RE et al. Binding of serum immunoglobulins to collagens in IgA nephropathy and HIV infection. Kidney Int 1992; 42:374-82.
27. Novak J, Milan T, Karel M et al. IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells. Kidney Int 2005; 67:504-13.
28. Coppo R, Amore A. Aberrent glycosylation in IgA nephropathy (IgAN). Kidney Int 2004; 65:1544-7.
29. Iwase H, Tanaka A, Hiki Y et al. Aggregated human serum immunoglobulin A1 induced by neuraminidase treatment had a lower number of O-linked sugar chains on the hinge portion. J Chromatogr B 1999; 724:1-7.
30. Hashim OH, Shuib AS, Chua CT. The interaction of selective plant lectins with neuraminidase-treated and untreated IgA1 from the sera of IgA nephropathy patients. Immunol-Invest 2001; 30:21-31.
31. Yasuda Y, Horie A, Odani H, Iwase H, Hiki Y. Application of mass spectrometry to IgA nephropathy. structural and biological analyses of underglycosylated IgA1 molecules. Contrib Nephrol 2004; 141:170-88.
32. Kokubo T, Hiki Y, Iwase H et al. Protective role of IgA1 glycans against IgA1 self-aggregation and adhesion to extracellular matrix proteins. J Am Soc Nephrol 1998; 9:2048-54.
33. Milan T, Matousovic K, Julian BA, Konecny K, Mestecky J. Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG. Kidney Int 1997; 52:509-16.
34. Milan T, Novak J, Julian BA, Matousovic K, Konecny K, Mestecky J. Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies. J Clin Invest 1999; 104:73-81.
35. Nakamura I, Iwase H, Arai K et al. Detection of gender difference and epitope specificity of IgG antibody activity against IgA1 hinge portion in IgA nephropathy patients by using synthetic hinge peptide and glycopeptide probes. Nephrology 2004; 9:26-30.
36. Kokubo T, Hashizume K, Iwase H et al. Humoral immunity against the proline-rich peptide epitope of the IgA1 hinge region in IgA nephropathy. Nephrol Dial Transplant 2000; 15:28-33.
37. Kokubo T, Hiki Y, Iwase H et al. Exposed peptide core of IgA1 hinge region in IgA nephropathy. Nephrol Dial Transplant 1999; 14:81-5.
38. Kokubo T, Hiki Y, Iwase H et al. Evidence for involvement of IgA1 hinge glycopeptide in the IgA1-IgA1 interaction in IgA nephropathy. J Am Soc Nephrol 1997; 8:915-9.
39. Hiki Y, Kokubo T, Iwase H et al. Underglycosylation of IgA1 hinge plays a certain role for its glomerular deposition in IgA nephropathy. J Am Soc Nephrol 1999; 10:760-9.
40. van der Boog PJ, van Kooten C, de Fijter JW, Daha MR. Role of macromolecular IgA in IgA nephropathy. Kidney Int 2005; 67:813-21.
41. Mestecky J, Tomana M, Crowley-Nowick PA. Defective galactosylation and clearance of IgA1molecules as a possible etiopathogenic factor in IgA nephropathy. Contrib Nephrol 1993; 104:172-82.